Details for New Drug Application (NDA): 209353

✉ Email this page to a colleague

NDA 209353 describes ALTRENO, which is a drug marketed by Dow Pharm and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the ALTRENO profile page.

The generic ingredient in ALTRENO is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the tretinoin profile page.

Summary for 209353

Tradename:	ALTRENO
Applicant:	Dow Pharm
Ingredient:	tretinoin
Patents:	2

Pharmacology for NDA: 209353

Medical Subject Heading (MeSH) Categories for 209353

Antineoplastic Agents
Keratolytic Agents

Suppliers and Packaging for NDA: 209353

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ALTRENO	tretinoin	LOTION;TOPICAL	209353	NDA	Bausch Health US, LLC	0187-0005	0187-0005-03	6 TUBE in 1 CARTON (0187-0005-03) / 3 g in 1 TUBE
ALTRENO	tretinoin	LOTION;TOPICAL	209353	NDA	Bausch Health US, LLC	0187-0005	0187-0005-10	10 TUBE in 1 CARTON (0187-0005-10) / 3 g in 1 TUBE (0187-0005-04)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	LOTION;TOPICAL			Strength	0.05%
Approval Date:	Aug 23, 2018	TE:		RLD:	Yes
Patent:	⤷ Sign Up	Patent Expiration:	Aug 22, 2038	Product Flag?	Y	Substance Flag?		Delist Request?
Patented Use:	TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 9 YEARS OF AGE AND OLDER
Patent:	⤷ Sign Up	Patent Expiration:	Aug 22, 2038	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 9 YEARS OF AGE AND OLDER

Expired US Patents for NDA 209353

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dow Pharm	ALTRENO	tretinoin	LOTION;TOPICAL	209353-001	Aug 23, 2018	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.